Present Approaches to Testing Webinar: Optimizing Urine Drug Monitoring in an Evolving Clinical Landscape

Course overview

Controlled substance monitoring in urine has evolved substantially as prescribing practices, polysubstance use, regulatory expectations, and laboratory technologies have changed. Increasing use of gabapentin and pregabalin, greater recognition of polysubstance use, and broader adoption of definitive mass spectrometry have reshaped how clinicians evaluate medication adherence, unexpected results, and patient safety. This webinar reviews the evidence supporting modern urine drug monitoring, compares immunoassay, definitive, and hybrid testing strategies, and provides practical guidance for selecting testing based on clinical scenarios. Through case studies, participants will learn how to interpret common findings and how an integrated testing portfolio can support pain management, controlled substance monitoring, addiction medicine, and other practice settings.